Davis Capital Management
BSX icon

Davis Capital Management’s Boston Scientific BSX Stock Holding History

Davis Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$829 Sell
19
-25
-57% -$1.16K ﹤0.01% 539
2026
Q2 		$1.88K Buy
44
+21
+91% +$1.14K ﹤0.01% 398
2026
Q1 		$1.44K Buy
23
+15
+188% +$1.2K ﹤0.01% 311
2025
Q4 		$763 Hold
8
– – ﹤0.01% 359
2025
Q3 		$781 Buy
+8
New +$828 ﹤0.01% 359

Other funds holding BSX

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Davis Capital Management's BSX Position: Q3 2026 in Review

Davis Capital Management reduced its Boston Scientific (BSX) stake by 57% in Q3 2026, selling an estimated $1.16K and leaving 19 shares worth $829. The position accounts for ﹤0.01% of the portfolio, ranked #539.

Davis Capital Management first reported a position in BSX in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.88K in Q2 2026. 972 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Davis Capital Management held 19 shares of Boston Scientific worth $829 as of Q3 2026.
  • Davis Capital Management sold 25 Boston Scientific shares in Q3 2026, an estimated $1.16K.
  • Boston Scientific made up ﹤0.01% of Davis Capital Management's portfolio in Q3 2026, its #539 holding.
  • Davis Capital Management first reported a position in Boston Scientific in Q3 2025 and has held it in 5 quarters since.
  • Davis Capital Management's Boston Scientific position peaked at $1.88K in Q2 2026.
  • 972 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.